Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 15INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Drug Resistant Epilepsy 1Brain Neoplasms 1Autism Spectrum Disorder 1

Interventions

pembrolizumab 609Carboplatin 376Paclitaxel 283Cisplatin 269Gemcitabine 256Pemetrexed 195Bevacizumab 191Docetaxel 190Nivolumab 188Injections 169Cyclophosphamide 148atezolizumab 138Capecitabine 134Fluorouracil 133Oxaliplatin 132Dexamethasone 129durvalumab 114Fulvestrant 114130-nm albumin-bound paclitaxel 111fludarabine 102Cetuximab 101Leucovorin 97Rituximab 96venetoclax 90Lenalidomide 84Prednisone 79enzalutamide 78Azacitidine 76Irinotecan 73Ipilimumab 73

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Diet, Ketogenic × 1 year × Clear all
NCT06309251 2025-09-03

Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients

Danone Nutricia SpA Società Benefit

Recruiting
100 enrolled
CNS

Autism Spectrum Disorder, Drug Resistant Epilepsy, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡